| WKN: | A1J84E |
| ISIN: | US00287Y1091 |
| Land: | USA |
| Branche: | Chemie, Pharma, Bio- & Medizintechnik |
| Sektor: | Biotechnologie |
Weshalb die Abbvie-Aktie
ein AA-Rating hat,
erfahren Sie im Performance-Check
vom 12. Mai 2026 Info.
| Rang | Datum | Vorjahr | Schluss | Performance |
|---|---|---|---|---|
| 1 | 2014 | 38,24 | 55,42 | 44,93% |
| 2 | 2021 | 85,51 | 119,98 | 40,31% |
| 3 | 2017 | 59,33 | 81,88 | 38,01% |
| 4 | 2022 | 119,98 | 152,14 | 26,80% |
| 5 | 2024 | 139,20 | 171,00 | 22,84% |
| 6 | 2025 | 171,00 | 195,00 | 14,04% |
| 7 | 2016 | 54,18 | 59,33 | 9,51% |
| 8 | 2020 | 80,20 | 85,51 | 6,62% |
| 9 | 2019 | 78,78 | 80,20 | 1,80% |
| 10 | 2015 | 55,42 | 54,18 | -2,24% |
| 11 | 2018 | 81,88 | 78,78 | -3,79% |
| 12 | 2023 | 152,14 | 139,20 | -8,51% |
| 13 | 2026 | 195,00 | 170,20 | -12,72% |
| Rang | Datum | Vorjahr | Schluss | Performance |
|---|---|---|---|---|
| 1 | 2026 | 195,00 | 170,20 | -12,72% |
| 2 | 2023 | 152,14 | 139,20 | -8,51% |
| 3 | 2018 | 81,88 | 78,78 | -3,79% |
| 4 | 2015 | 55,42 | 54,18 | -2,24% |
| 5 | 2019 | 78,78 | 80,20 | 1,80% |
| 6 | 2020 | 80,20 | 85,51 | 6,62% |
| 7 | 2016 | 54,18 | 59,33 | 9,51% |
| 8 | 2025 | 171,00 | 195,00 | 14,04% |
| 9 | 2024 | 139,20 | 171,00 | 22,84% |
| 10 | 2022 | 119,98 | 152,14 | 26,80% |
| 11 | 2017 | 59,33 | 81,88 | 38,01% |
| 12 | 2021 | 85,51 | 119,98 | 40,31% |
| 13 | 2014 | 38,24 | 55,42 | 44,93% |